M&T Bank Corp Veracyte, Inc. Transaction History

M&T Bank Corp

$30.1 Billion
Q3 2024

A detailed history of M&T Bank Corp transactions in Veracyte, Inc. stock. As of the latest transaction made, M&T Bank Corp holds 61,261 shares of VCYT stock, worth $2.67 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

61,261

Previous 61,261 -0.0%

Holding current value

$2.67 Million

Previous $2.08 Million -0.0%

% of portfolio

0.01%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$21.0 - $35.25 $214,683 - $360,360	10,223 Added 20.03%	61,261 $2.08 Million
Q2 2024 Jul 31, 2024	BUY	$18.86 - $23.55 $101,825 - $127,146	5,399 Added 11.83%	51,038 $1.11 Million
Q1 2024 May 07, 2024	BUY	$21.0 - $29.1 $232,071 - $321,584	11,051 Added 31.95%	45,639 $1.01 Million
Q4 2023 Feb 06, 2024	BUY	$19.72 - $28.68 $108,381 - $157,625	5,496 Added 18.89%	34,588 $951,000
Q3 2023 Nov 02, 2023	SELL	$22.33 - $29.92 $36,665 - $49,128	-1,642 Reduced 5.34%	29,092 $649,000
Q2 2023 Aug 09, 2023	BUY	$20.96 - $26.99 $137,791 - $177,432	6,574 Added 27.21%	30,734 $782,000
Q1 2023 May 11, 2023	SELL	$20.58 - $27.89 $168,262 - $228,028	-8,176 Reduced 25.28%	24,160 $538,000
Q4 2022 Feb 13, 2023	SELL	$15.31 - $29.94 $704,198 - $1.38 Million	-45,996 Reduced 58.72%	32,336 $767,000
Q4 2022 Feb 13, 2023	BUY	$15.31 - $29.94 $710,414 - $1.39 Million	46,402 Added 145.32%	78,332 $1.86 Million
Q3 2022 Nov 14, 2022	SELL	$16.58 - $27.9 $82,336 - $138,551	-4,966 Reduced 13.46%	31,930 $531,000
Q2 2022 Aug 05, 2022	BUY	$15.45 - $29.52 $347,192 - $663,373	22,472 Added 155.8%	36,896 $734,000
Q1 2022 May 09, 2022	BUY	$21.94 - $42.51 $63,516 - $123,066	2,895 Added 25.11%	14,424 $398,000
Q4 2021 Feb 07, 2022	BUY	$36.09 - $53.79 $22,700 - $33,833	629 Added 5.77%	11,529 $475,000
Q3 2021 Oct 28, 2021	SELL	$35.62 - $52.97 $7,337 - $10,911	-206 Reduced 1.85%	10,900 $506,000
Q2 2021 Aug 13, 2021	BUY	$32.94 - $56.62 $40,318 - $69,302	1,224 Added 12.39%	11,106 $444,000
Q1 2021 May 06, 2021	SELL	$44.47 - $81.38 $189,797 - $347,329	-4,268 Reduced 30.16%	9,882 $531,000
Q4 2020 Feb 12, 2021	SELL	$32.49 - $61.88 $41,034 - $78,154	-1,263 Reduced 8.19%	14,150 $692,000
Q3 2020 Nov 06, 2020	BUY	$26.73 - $35.67 $49,797 - $66,453	1,863 Added 13.75%	15,413 $501,000
Q2 2020 Jul 29, 2020	BUY	$19.49 - $28.11 $16,897 - $24,371	867 Added 6.84%	13,550 $351,000
Q1 2020 May 14, 2020	BUY	$16.13 - $30.17 $204,576 - $382,646	12,683 New	12,683 $308,000

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.11B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account